BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnson KM, Belfer JJ, Peterson GR, Boelkins MR, Dumkow LE. Managing COVID-19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid-sparing Immunosuppression. Pharmacotherapy 2020;40:517-24. [PMID: 32339304 DOI: 10.1002/phar.2410] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 21.5] [Reference Citation Analysis]
Number Citing Articles
1 Lai Q, Spoletini G, Bianco G, Graceffa D, Agnes S, Rossi M, Lerut J. SARS-CoV2 and immunosuppression: A double-edged sword. Transpl Infect Dis 2020;22:e13404. [PMID: 32639598 DOI: 10.1111/tid.13404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
2 Sagnelli C, Sica A, Gallo M, Peluso G, Varlese F, D'Alessandro V, Ciccozzi M, Crocetto F, Garofalo C, Fiorelli A, Iannuzzo G, Reginelli A, Schonauer F, Santangelo M, Sagnelli E, Creta M, Calogero A. Renal involvement in COVID-19: focus on kidney transplant sector. Infection 2021;49:1265-75. [PMID: 34611792 DOI: 10.1007/s15010-021-01706-6] [Reference Citation Analysis]
3 May MR, Rübben A, Lennertz A, Vanstreels L, Leijs M. Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection. JPM 2022;12:173. [DOI: 10.3390/jpm12020173] [Reference Citation Analysis]
4 Moussa M, Chakra MA, Papatsoris AG, Dellis A. The Impact of COVID-19 Disease on Urology Practice. Surg J (N Y) 2021;7:e83-91. [PMID: 34104720 DOI: 10.1055/s-0041-1725155] [Reference Citation Analysis]
5 Daoud A, Alqassieh A, Alkhader D, Posadas Salas MA, Rao V, Fülöp T, Soliman KM. Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading? Ren Fail 2021;43:273-80. [PMID: 33491531 DOI: 10.1080/0886022X.2021.1876730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Oellerich M, Sherwood K, Keown P, Schütz E, Beck J, Stegbauer J, Rump LC, Walson PD. Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury. Nat Rev Nephrol 2021;17:591-603. [PMID: 34031575 DOI: 10.1038/s41581-021-00428-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Heron VC, Bach CT, Holmes NE, Whitlam JB. Complete recovery from COVID-19 of a kidney-pancreas transplant recipient: potential benefit from everolimus? BMJ Case Rep 2021;14:e238413. [PMID: 33431539 DOI: 10.1136/bcr-2020-238413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Duettmann W, Naik MG, Zukunft B, Osmonodja B, Bachmann F, Choi M, Roller R, Mayrdorfer M, Halleck F, Schmidt D, Budde K. eHealth in transplantation. Transpl Int 2021;34:16-26. [DOI: 10.1111/tri.13778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Dedinská I, Skálová P, Graňák K, Vnučák M, Baltesová T, Žilinská Z, Jeseňák M. The Role of HLA Antigens and Steroid Dose on the Course of COVID-19 of Patients After Kidney Transplantation. Front Med (Lausanne) 2021;8:730156. [PMID: 34790673 DOI: 10.3389/fmed.2021.730156] [Reference Citation Analysis]
10 Marinaki S, Tsiakas S, Skalioti C, Lourida P, Argyraki A, Grigorakos K, Boletis I. A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece. Medicina (Kaunas) 2020;56:E355. [PMID: 32708858 DOI: 10.3390/medicina56070355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Maritati F, Cerutti E, Zuccatosta L, Fiorentini A, Finale C, Ficosecco M, Cristiano F, Capestro A, Balestra E, Taruscia D, Vivarelli M, Donati A, Perna GP, Giacometti A, Tavio M, Onesta M, Di Sante L, Ranghino A. SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region. Transpl Infect Dis 2020;22:e13377. [PMID: 32573895 DOI: 10.1111/tid.13377] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
12 Bitencourt L, Pedrosa AL, de Brito SBCS, Fróes ACF, de Carvalho ST, Fonseca GG, Ferreira GC, Fradico PF, Simões E Silva AC. COVID-19 and Renal Diseases: An Update. Curr Drug Targets 2021;22:52-67. [PMID: 33050860 DOI: 10.2174/1389450121999201013151300] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Hidalgo-blanco MÁ, Andreu i Periz D, Moreno-arroyo MC. COVID-19 en el enfermo renal. Revisión breve. Enferm Nefrol. [DOI: 10.37551/s2254-28842020013] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kataria A, Yakubu I, Winstead R, Gowda M, Gupta G. COVID-19 in Kidney Transplantation: Epidemiology, Management Considerations, and the Impact on Kidney Transplant Practice. Transplant Direct 2020;6:e582. [PMID: 33134506 DOI: 10.1097/TXD.0000000000001031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
15 Nahi SL, Shetty AA, Tanna SD, Leventhal JR. Renal allograft function in kidney transplant recipients infected with SARS-CoV 2: An academic single center experience. PLoS One 2021;16:e0252979. [PMID: 34111211 DOI: 10.1371/journal.pone.0252979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Reference Citation Analysis]
17 Bruno PF, Cappuccilli M, Spazzoli A, De Liberali M, Sejdiu B, Napoli M, Minerva V, Semprini S, Dirani G, Sambri V, Buscaroli A, Rigotti A, Mancini E, Masperi P, La Manna G, Mosconi G. COVID-19 Infection: Viral Clearance and Antibody Response in Dialysis Patients and Renal Transplant Recipients. Nephron 2021;145:363-70. [PMID: 33902031 DOI: 10.1159/000515128] [Reference Citation Analysis]
18 El-Saber Batiha G, Al-Gareeb AI, Saad HM, Al-Kuraishy HM. COVID-19 and corticosteroids: a narrative review. Inflammopharmacology 2022. [PMID: 35562628 DOI: 10.1007/s10787-022-00987-z] [Reference Citation Analysis]
19 Domínguez-gil B, Fernández-ruiz M, Hernández D, Crespo M, Colmenero J, Coll E, Rubio JJ. Organ Donation and Transplantation During the COVID-19 Pandemic: A Summary of the Spanish Experience. Transplantation 2021;105:29-36. [DOI: 10.1097/tp.0000000000003528] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
20 Quante M, Brake L, Tolios A, Della Penna A, Steidle C, Gruendl M, Grishina A, Haeberle H, Guthoff M, Tullius SG, Königsrainer A, Nadalin S, Löffler MW. SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020. Transplant Proc 2021;53:2421-34. [PMID: 34551880 DOI: 10.1016/j.transproceed.2021.08.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kolonko A, Dudzicz S, Wiecek A, Król R. COVID-19 infection in solid organ transplant recipients: A single-center experience with patients immediately after transplantation. Transpl Infect Dis 2021;23:e13381. [PMID: 32578289 DOI: 10.1111/tid.13381] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
22 Molaei H, Khedmat L, Nemati E, Rostami Z, Saadat SH. Iranian kidney transplant recipients with COVID-19 infection: Clinical outcomes and cytomegalovirus coinfection. Transpl Infect Dis 2021;23:e13455. [PMID: 32881220 DOI: 10.1111/tid.13455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Demir E, Uyar M, Parmaksiz E, Sinangil A, Yelken B, Dirim AB, Merhametsiz O, Yadigar S, Atan Ucar Z, Ucar AR, Demir ME, Mese M, Akin EB, Garayeva N, Safak S, Oto OA, Yazici H, Turkmen A. COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul. Transpl Infect Dis 2020;22:e13371. [PMID: 32657540 DOI: 10.1111/tid.13371] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
24 Khokhar M, Purohit P, Roy D, Tomo S, Gadwal A, Modi A, Banerjee M, Sharma P. Acute kidney injury in COVID 19 – an update on pathophysiology and management modalities. Archives of Physiology and Biochemistry. [DOI: 10.1080/13813455.2020.1856141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Jilich D, Skrzat-Klapaczyńska A, Fleischhans L, Bursa D, Antoniak S, Balayan T, Begovac J, Cicic A, Dragovic G, Goekengin D, Harxhi A, Kase K, Lakatos B, Matulionyte R, Mulabdic V, Oprea C, Papadopoulos A, Rukhadze N, Tomazic J, Tovba L, Soják Ľ, Vassilenko A, Yancheva N, Yurin O, Kowalska J; ECEE Network Group. National strategies for vaccination against COVID-19 in people living with HIV in Central and Eastern European region. HIV Med 2021. [PMID: 34704331 DOI: 10.1111/hiv.13194] [Reference Citation Analysis]
26 Dahl Mathiasen V, Jensen-Fangel S, Skov K, Leth S. Uneventful case of COVID-19 in a kidney transplant recipient. BMJ Case Rep 2020;13:e237427. [PMID: 32690572 DOI: 10.1136/bcr-2020-237427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Çınar G, Sarıcaoğlu C, İnan B, Dinçer İ, Çakıcı M, Sayın T, Azap A, Akar AR. Heart transplant recipient survivor from COVID-19: The first case of Turkey. Turk Gogus Kalp Damar Cerrahisi Derg 2020;28:674-9. [PMID: 33403142 DOI: 10.5606/tgkdc.dergisi.2020.20291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Mcadams M, Ostrosky-frid M, Rajora N, Hedayati S. Effect of COVID-19 on Kidney Disease Incidence and Management. Kidney360 2021;2:141-53. [DOI: 10.34067/kid.0006362020] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Mardani M, Hakamifard A. COVID-19 and immunocompromised conditions: Ongoing challenging issue. Eur J Inflamm 2021;19:205873922110161. [DOI: 10.1177/20587392211016114] [Reference Citation Analysis]
30 Li J, Chen G, Zhang M, Tu S, Chen C. Different clinical presentations of two renal transplant recipients with coronavirus disease 2019: a case report. BMC Infect Dis 2020;20:707. [PMID: 32977764 DOI: 10.1186/s12879-020-05434-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Fernández-Niño JA, Guerra-Gómez JA, Idrovo AJ. Multimorbidity patterns among COVID-19 deaths: proposal for the construction of etiological models. Rev Panam Salud Publica 2020;44:e166. [PMID: 33417654 DOI: 10.26633/RPSP.2020.166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
32 Ahmadian E, Zununi Vahed S, Mammadova S, Abediazar S. Immunosuppressant Management in Renal Transplant Patients with COVID-19. Biomed Res Int 2021;2021:9318725. [PMID: 34692845 DOI: 10.1155/2021/9318725] [Reference Citation Analysis]
33 Moore JL, Ganapathiraju PV, Kurtz CP, Wainscoat B. A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma. Am J Case Rep 2020;21:e927812. [PMID: 33009361 DOI: 10.12659/AJCR.927812] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
34 Das B. Presentation of SARS-CoV-2 in a Pediatric Heart Transplant Recipient with Multiple Underlying Comorbidities. Transplantology 2021;2:87-91. [DOI: 10.3390/transplantology2010009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Moosavi SA, Mashhadiagha A, Motazedian N, Hashemazar A, Hoveidaei AH, Bolignano D. COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases. Transpl Infect Dis 2020;22:e13427. [PMID: 32779820 DOI: 10.1111/tid.13427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
36 Liu J, Du C, Pu L, Xiang P, Xiong H, Xie W, Chen Z, Li A. Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2. BMC Infect Dis 2021;21:885. [PMID: 34461841 DOI: 10.1186/s12879-021-06595-6] [Reference Citation Analysis]
37 Kantarcioglu B, Iqbal O, Lewis J, Carter CA, Singh M, Lievano F, Ligocki M, Jeske W, Adiguzel C, Gerotziafas GT, Fareed J. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations. Clin Appl Thromb Hemost 2022;28:107602962110566. [DOI: 10.1177/10760296211056648] [Reference Citation Analysis]
38 Rahbar M, Sharifi Y, Kazem Aghamir SM. A case of COVID-19 infection in a kidney transplant recipient after receiving the single dose of COVID-19 vaccination. Annals of Medicine and Surgery 2022;77:103517. [DOI: 10.1016/j.amsu.2022.103517] [Reference Citation Analysis]
39 Pileggi GS, Ferreira GA, Reis APMG, Reis-Neto ET, Abreu MM, Albuquerque CP, Araújo NC, Bacchiega AB, Bianchi DV, Bica B, Bonfa ED, Borba EF, Brito DCSE, Duarte ÂLBP, Santo RCE, Fernandes PR, Guimarães MP, Gomes KWP, Kakehasi AM, Klumb EM, Lanna CCD, Marques CDL, Monticielo OA, Mota LMH, Munhoz GA, Paiva ES, Pereira HLA, Provenza JR, Ribeiro SLE, Junior LFR, Sampaio CSJC, Sampaio VS, Sato EI, Skare T, de Souza VA, Valim V, Lacerda MVG, Xavier RM, Pinheiro MM. Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil. Adv Rheumatol 2021;61:60. [PMID: 34620246 DOI: 10.1186/s42358-021-00217-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Imam A, Abukhalaf SA, Imam R, Abu-Gazala S, Merhav H, Khalaileh A. Kidney Transplantation in the Times of COVID-19 - A Literature Review. Ann Transplant 2020;25:e925755. [PMID: 32703929 DOI: 10.12659/AOT.925755] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
41 Clarke C, Lucisano G, Prendecki M, Gleeson S, Martin P, Ali M, McAdoo SP, Lightstone L, Ashby D, Charif R, Griffith M, McLean A, Dor F, Willicombe M; ICHNT Renal COVID Group. Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era. Kidney Int Rep 2021;6:46-55. [PMID: 33173838 DOI: 10.1016/j.ekir.2020.10.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
42 Dashti-khavidaki S, Mohammadi K, Khalili H, Abdollahi A. Pharmacotherapeutic considerations in solid organ transplant patients with COVID-19. Expert Opinion on Pharmacotherapy 2020;21:1813-9. [DOI: 10.1080/14656566.2020.1790526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
43 Giusti S, Chazin S, Vaitla P, Atiemo K, Atari M, Paramesh A, Jeon H, Torres-Ortiz A, Thimmisetty R, Garces J. Observational Study of the Clinical Characteristics and Short-Term Outcomes of Kidney Transplant Recipients Diagnosed With COVID-19 Infection (SARS-CoV-2) Requiring Hospitalization in New Orleans. Ochsner J 2021;21:329-34. [PMID: 34984045 DOI: 10.31486/toj.21.0008] [Reference Citation Analysis]
44 Yılmaz EA, Özdemir Ö. Solid organ transplantations and COVID-19 disease. World J Transplant 2021; 11(12): 503-511 [DOI: 10.5500/wjt.v11.i12.503] [Reference Citation Analysis]
45 Lum E, Bunnapradist S, Multani A, Beaird OE, Carlson M, Gaynor P, Kotton C, Abdalla B, Danovitch G, Kendrick E, Nieves-Borrero K, Pham PT, Yabu J, Schaenman J. Spectrum of Coronavirus Disease 2019 Outcomes in Kidney Transplant Recipients: A Single-Center Experience. Transplant Proc 2020;52:2654-8. [PMID: 33041077 DOI: 10.1016/j.transproceed.2020.09.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
46 Vaid N, Ardissino M, Reed TAN, Goodall J, Utting P, Miscampbell M, Condurache D, Cohen DL. Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID-19: experience from London. J Intern Med 2021;289:385-94. [PMID: 32902028 DOI: 10.1111/joim.13172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
47 Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, Eyerich S, Ghoreschi K, Goebeler M, Ludwig RJ, Schäkel K, Schilling B, Schlapbach C, Stary G, von Stebut E, Steinbrink K. COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen. J Dtsch Dermatol Ges 2020;18:795-809. [PMID: 32881300 DOI: 10.1111/ddg.14169_g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, Eyerich S, Ghoreschi K, Goebeler M, Ludwig RJ, Schäkel K, Schilling B, Schlapbach C, Stary G, von Stebut E, Steinbrink K. COVID-19 and immunological regulations - from basic and translational aspects to clinical implications. J Dtsch Dermatol Ges 2020;18:795-807. [PMID: 32761894 DOI: 10.1111/ddg.14169] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
49 Babel N, Anft M, Blazquez-Navarro A, Doevelaar AAN, Seibert FS, Bauer F, Rohn BJ, Hoelzer B, Thieme CJ, Roch T, Meister TL, Pfaender S, Steinmann E, Dittmer U, Schenker P, Amann K, Viebahn R, Stervbo U, Westhoff TH. Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient. Am J Transplant 2020;20:3210-5. [PMID: 32777178 DOI: 10.1111/ajt.16252] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
50 Negahdaripour M, Shafiekhani M, Moezzi SMI, Amiri S, Rasekh S, Bagheri A, Mosaddeghi P, Vazin A. Administration of COVID-19 vaccines in immunocompromised patients. Int Immunopharmacol 2021;99:108021. [PMID: 34352567 DOI: 10.1016/j.intimp.2021.108021] [Reference Citation Analysis]
51 Andersen KM, Mehta HB, Palamuttam N, Ford D, Garibaldi BT, Auwaerter PG, Segal J, Alexander GC. Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System. Clin Infect Dis 2021:ciaa1488. [PMID: 33410884 DOI: 10.1093/cid/ciaa1488] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
52 Raja MA, Mendoza MA, Villavicencio A, Anjan S, Reynolds JM, Kittipibul V, Fernandez A, Guerra G, Camargo JF, Simkins J, Morris MI, Abbo LA, Natori Y. COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature. Transplant Rev (Orlando). 2021;35:100588. [PMID: 33246166 DOI: 10.1016/j.trre.2020.100588] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 15.0] [Reference Citation Analysis]
53 Hasan I, Rashid T, Suliman S, Amer H, Chirila RM, Mai ML, Jarmi T, Khouzam S, Franco PM, Heilig CW, Wadei HM. Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample. Rom J Intern Med 2021;59:10-42. [PMID: 33155999 DOI: 10.2478/rjim-2020-0034] [Cited by in F6Publishing: 2] [Reference Citation Analysis]